CERULEAN PHARMA INC's ticker is CERU and the CUSIP is 15708Q105. A total of 19 filers reported holding CERULEAN PHARMA INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $43,000 | – | 25,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 3,287,529 | $8,909,000 | 8.51% |
| Polaris Venture Management Co IV LLC | 1,437,441 | $3,895,000 | 7.33% |
| Rock Springs Capital Management LP | 625,000 | $1,694,000 | 0.14% |
| Deer VII & Co. Ltd. | 166,675 | $452,000 | 0.12% |
| Granahan Investment Management | 730,015 | $1,978,000 | 0.07% |
| Northeast Financial Consultants Inc | 20,000 | $54,000 | 0.03% |
| Donald L. Hagan, LLC | 3,900 | $11,000 | 0.01% |
| Alyeska Investment Group, L.P. | 312,809 | $848,000 | 0.01% |
| WEDBUSH SECURITIES INC | 16,000 | $43,000 | 0.01% |
| TFS CAPITAL LLC | 15,895 | $43,000 | 0.01% |